CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Net sales	$ 78,357	$ 112,370	$ 266,390	$ 372,769
Cost of sales	72,658	82,063	230,656	298,738
Amortization of intangibles	2,621	3,851	10,425	21,097
Gross profit	3,078	26,456	25,309	52,934
Operating expenses:
Research and development expenses	5,807	5,973	16,318	18,156
Selling, general and administrative expenses	17,572	17,636	55,268	46,502
Restructuring expenses	1,782		2,673	4,043
Asset impairment charges			49,361	198,000
Total operating expenses	25,161	23,609	123,620	266,701
Operating income (loss)	(22,083)	2,847	(98,311)	(213,767)
Other income (expense):
Investment income	34	80	114	168
Interest expense	(14,517)	(12,631)	(43,171)	(40,613)
Other	303	18	252	23
Total other expense	(14,180)	(12,533)	(42,805)	(40,422)
Loss before income tax	(36,263)	(9,686)	(141,116)	(254,189)
Income tax benefit	(1,365)	(2,544)	(2,791)	(68,600)
Net loss	$ (34,898)	$ (7,142)	$ (138,325)	$ (185,589)
Loss per common share:
Basic (in dollars per share)	$ (0.86)	$ (0.18)	$ (3.44)	$ (4.72)
Diluted (in dollars per share)	$ (0.86)	$ (0.18)	$ (3.44)	$ (4.72)
Weighted average common shares outstanding:
Basic (in shares)	40,503,301	39,511,296	40,261,330	39,340,670
Diluted (in shares)	40,503,301	39,511,296	40,261,330	39,340,670